In light of this, our findings may indicate that even though there is a decrease in HDL-C levels in CRC patients, cholesterol is increasingly produced in peripheral tissues and transported by HDL to malignant cells in order to be taken up via SR-B1. The gene discussed is SCARB1; the disease is colorectal carcinoma.